2018 | 96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection | JOURNAL OF HEPATOLOGY |
2019 | A multicenter study of entecavir vs. tenofovir on prognosis of treatment-naïve chronic hepatitis B in South Korea | Journal of Hepatology |
2023 | A multisociety Delphi consensus statement on new fatty liver disease nomenclature
| JOURNAL OF HEPATOLOGY |
2020 | A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement | JOURNAL OF HEPATOLOGY |
2020 | A nomogram based on liver stiffness predicts postoperative complications in patients with hepatocellular carcinoma | JOURNAL OF HEPATOLOGY |
2023 | A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis | JOURNAL OF HEPATOLOGY |
2022 | An artificial intelligence model to predict hepatocellular carcinoma risk in Korean and Caucasian patients with chronic hepatitis B | JOURNAL OF HEPATOLOGY |
2003 | Apoptosis of hepatic stellate cells in carbon tetrachloride induced acute liver injury of the rat: analysis of isolated hepatic stellate cells | JOURNAL OF HEPATOLOGY |
2022 | Asian perspective on NAFLD-associated HCC | JOURNAL OF HEPATOLOGY |
2018 | Association of non-alcoholic steatohepatitis with subclinical myocardial dysfunction in non-cirrhotic patients | JOURNAL OF HEPATOLOGY |
2020 | Clinical relevance of dynamic risk assessment for developing hepatocellular carcinoma during prolonged antiviral therapy | JOURNAL OF HEPATOLOGY |
2015 | Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinoma | JOURNAL OF HEPATOLOGY |
2024 | Efficacy of stereotactic ablative radiotherapy in patients with oligometastatic hepatocellular carcinoma: A phase II study | JOURNAL OF HEPATOLOGY |
2019 | Efficient long-term amplification of hepatitis B virus isolates after infection of slow proliferating HepG2-NTCP cells
| JOURNAL OF HEPATOLOGY |
2001 | Emergence of YMDD motif mutant of hepatitis B virus during short-term lamivudine therapy in South Korea | JOURNAL OF HEPATOLOGY |
2020 | Functions of human liver CD69 + CD103 - CD8 + T cells depend on HIF-2α activity in healthy and pathologic livers | JOURNAL OF HEPATOLOGY |
2003 | Gliotoxin-mediated apoptosis of activated human hepatic stellate cells | JOURNAL OF HEPATOLOGY |
2022 | Head-to-head comparison between MEFIB, MAST, and FAST for detecting stage 2 fibrosis or higher among patients with NAFLD | JOURNAL OF HEPATOLOGY |
2016 | Hepatic expression of Sonic Hedgehog induces liver fibrosis and promotes hepatocarcinogenesis in a transgenic mouse model | JOURNAL OF HEPATOLOGY |
2020 | Human liver CD8 + MAIT cells exert TCR/MR1-independent innate-like cytotoxicity in response to IL-15 | JOURNAL OF HEPATOLOGY |
2021 | Hyperprogressive disease during PD-1 blockade in patients with advanced hepatocellular carcinoma | JOURNAL OF HEPATOLOGY |
2022 | Identification of a distinct NK-like hepatic T-cell population activated by NKG2C in a TCR-independent manner
| JOURNAL OF HEPATOLOGY |
2020 | IFNL3-adjuvanted HCV DNA vaccine reduces regulatory T cell frequency and increases virus-specific T cell responses | JOURNAL OF HEPATOLOGY |
2017 | Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis | JOURNAL OF HEPATOLOGY |
2005 | Long-term clinical and histological outcomes in patients with spontaneous hepatitis B surface antigen seroclearance | JOURNAL OF HEPATOLOGY |
2017 | New trends on obesity and NAFLD in Asia | JOURNAL OF HEPATOLOGY |
2017 | NS5A resistance-associated substitutions in patients with genotype 1 hepatitis C virus: Prevalence and effect on treatment outcome | JOURNAL OF HEPATOLOGY |
2023 | Overall survival and objective response in advanced unresectable hepatocellular carcinoma: A subanalysis of the REFLECT study
| JOURNAL OF HEPATOLOGY |
2024 | PAGE-B incorporating moderate HBV DNA levels predicts risk of HCC among patients entering into HBeAg-positive chronic hepatitis B | JOURNAL OF HEPATOLOGY |
2016 | Peginterferon lambda for the treatment of HBeAg-positive chronic hepatitis B: A randomized phase 2b study (LIRA-B) | JOURNAL OF HEPATOLOGY |
2004 | Primary liver carcinoma of intermediate (hepatocyte–cholangiocyte) phenotype | JOURNAL OF HEPATOLOGY |
2022 | Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on HBV genotype and viral antigen levels
| JOURNAL OF HEPATOLOGY |
2020 | Reassessing the accuracy of PAGE-B-related scores to predict hepatocellular carcinoma development in patients with chronic hepatitis B | JOURNAL OF HEPATOLOGY |
2020 | Reply to: "Comment on - A multi-center study of entecavir vs. tenofovir on prognosis of treatment-naïve chronic hepatitis B in the Republic of Korea" | JOURNAL OF HEPATOLOGY |
2019 | Reply to: "Comparison of risk of hepatocellular carcinoma between tenofovir and entecavir: One direction or no direction" | JOURNAL OF HEPATOLOGY |
2020 | Reply to: "Liver stiffness: A novel predictor of postoperative complications in patients with hepatocellular carcinoma" | JOURNAL OF HEPATOLOGY |
2020 | Reply to: "Response to A nomogram based on liver stiffness predicts postoperative complications in patients with hepatocellular carcinoma" | JOURNAL OF HEPATOLOGY |
2014 | Role of desmoplasia in cholangiocarcinoma and hepatocellular carcinoma
| JOURNAL OF HEPATOLOGY |
2018 | Safety, efficacy and pharmacodynamics of vesatolimod (GS-9620) in virally suppressed patients with chronic hepatitis B | JOURNAL OF HEPATOLOGY |
2015 | Sarcopaenia is associated with NAFLD independently of obesity and insulin resistance: Nationwide surveys (KNHANES 2008-2011) | JOURNAL OF HEPATOLOGY |
2016 | Sorafenib or placebo plus TACE with doxorubicin-eluting beads for intermediate stage HCC: The SPACE trial | JOURNAL OF HEPATOLOGY |
2018 | Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study | JOURNAL OF HEPATOLOGY |
2012 | The Laennec staging system for histological sub-classification of cirrhosis is useful for stratification of prognosis in patients with liver cirrhosis | JOURNAL OF HEPATOLOGY |
2015 | Two-year treatment outcome of chronic hepatitis B infection treated with besifovir vs. entecavir: results from a multicentre study. | JOURNAL OF HEPATOLOGY |